Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina

NCT04472078 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.

NCT NCT04472078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04472078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina
Lead sponsor
Hospital Italiano de Buenos Aires
Phase
Observational
Overall status
Completed
Start date
June 10, 2020
Completion date
December 11, 2020
Enrollment
873 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2